Session 1294: Prognostic Markers
Cochair(s): H Bartsch, N Phillips
Date: Tue 12 February 2002,
Time: 14:00 - 15:30
Location: CIS Auditorium
Oral Presentations
| Time |
Number |
Title / Authors / Affiliations |
| 14:00 |
327 |
Incidental
prostate cancer-prognostic factors. A population
based-study from Orebro,Sweden with 20 years
follow-up.
O Andren, S Andersson, J Johansson
Department of Urology
and Department of Pathology, University hospital of
Orebro Sweden |
| 14:15 |
328 |
Constitutive
expression of MHC class II molecules in melanoma cell
lines is due to a constitutive transcription of CIITA
from its promoter III
V Deffrennes, J Vedrenne, MC Stolzenberg, G Barbieri, F
Baton, J Piskurich, J Ting, D Charron, C
Alcaide-Loridan
1INSERM U396,
Centre de Recherches Biomedicales des Cordeliers, Paris,
France, 2Department of Microbiology and
Immunology, Lineberger Comprehensive Cancer Center,
Chapel Hill, USA |
| 14:30 |
329 |
Expressed gene
clusters with distinct prognostic properties of primary
breast tumors
K Iwao, R Matoba, S Noguchi, K Kato
1Taisho
Laboratory of Functional Genomics, Nara Institute of
Science and Technology, Ikoma, and,
2Department of Surgical Oncology, Osaka
University Medical School, Osaka, Japan |
| 14:45 |
330 |
Regulation of
cancer cell proliferation and survival by β 1
integrins
M Fornaro, D Zheng, M Manzotti, G Tallini, LR
Languino
Department of Pathology,
Department of Pathology, European Institute of Oncology,
Yale University School of Medicine, New Haven, and,
MD20141 Milan |
| 15:00 |
331 |
Expression of
UGT2B7, a glucuronosyltransferase implicated in the
inactivation of 4-hydroxyestrone, and in maintaining the
activity of retinoic acid, is enhanced in human breast
carcinoma in situ, but reduced or abrogated in invasive
breast cancer.
J Weisz
Pennsylvania State
University College of Medicine, Hershey, PA United
States |
| 15:15 |
332 |
Realities of
microsatellite instability in human
cancer
S Oda, Y Maehara, K Sugimachi
1Institute
for Clinical Research, National Cancer Centre, Fukuoka,
Japan, 2Cancer Centre, Kyushu University
Hospital, Fukuoka, Japan |
Poster Presentations
| Number |
Title / Authors / Affiliations |
| 333 |
Phenotype
modulation of tumor cell growth outlined by cell
morphological patterns.
MAA Castro, F Klamt, G Schwartsmann, I Grivicich, JCF
Moreira
1Departamento
de Bioquimica, Universidade Federal do Rio Grande do Sul,
Porto Alegre, Brazil, 2Lutheran University of
Brazil, Canoas, Brazil, 3SOAD, Comprehensive
Cancer Center, Lutheran University of Brazil, Canoas,
Brazil |
| 334 |
A pathology
sub-study of putative prognostic markers in colorectal
cancer.
Dr SA Grumett, P Quirke, DJ Kerr, M Conkey, J Stahlsmidt,
J Barnwell
1Institute
for Cancer Studies, University of Birmingham, ,
2Department of Pathology, UK c Department of
Clinical Pharmacology, University of Leeds, University of
Oxford |
| 335 |
Androgen receptor
CAG repeat polymorphism in prostate cancer from a
Brazilian population.
ML Santos, AS Sarkis, IN Nishimoto, PhD Nagai
1Departamento
de Radiologia, Universidade de Sao Paulo, Brazil,
2Divisão de Clínica Urológica, Depto de
Urologia, Brazil, 3Hospital AC Camargo, São
Paulo, Brazil |
| 336 |
Salivary levels
of NF-kappa B dependent cytokines of patients with oral
squamous cell carcinoma
NL Rhodus, VU Ho, CS Miller, J Burt, F Ondrey
University of Minnesota,
Minneapolis, MN |
| 337 |
*Mutational
alterations of connexin 43 associated with advanced stage
of progression of human colon cancer
VA Krutovskikh, NA Iaitckil, V DE Popov, MV Dubina
International Agency for
Research on Cancer Unit of Gene-Environment Interactions
150 cours Albert Thomas F-69372 Lyon 08,
France |
| 338 |
Prognostic value
of the response to induction chemotherapy in patients
with locally advanced inoperable urothelial
cancer
JW de Beukelaar, TA Splinter, CC Rijt, PI Schmitz, WJ
Kirkels
1Department
of Medical Oncology, 2Department of
Biostatistics, and, 3Department of; Urology of
the Erasmus University Medical Centre Rotterdam, the
Netherlands |
| 339 |
Genetic
polymorphisms in the tumor necrosis factor (TNF) gene
promoter influence non-Hodgkin's lymphoma
outcome.
P Juszczynski, E Kalinka, G Salles, G Woszczek, M
Borowiec, E Lech-Maranda, L Baseggio, M Kowalski, T
Robak, B Coiffier, K Warzocha
1Department
of Hematology, 2Department of Clinical
Immunology; Medical University of Lodz, Poland, and,
3Service d'Hematologie, Centre Hospitalier
Lyon-Sud, Pierre Benite, France |
| 340 |
Telomerase
expression in prostate cancer imprint smears of patients
treated with radical prostatectomy
A Bantis, P Athanassiadou, M Gonidi, A Kyriakidis, A
Liossi, E Petrakakou, P Athanassiades, A
Giannopoulos
a Pathology Laboratory,
Cytology Department b Urology Clinic Laiko Hospital,
Medical School University of Athens and Urology Clinic
Hippocration Hospital, Athens, Greece |
| 341 |
Telomerase
activity and Metallothionein expression in renal cell
carcinomas
A Ioakim-Liossi, P Athanassiadou, D Pantazopoulos, P
Karakitsos, A Karkabasi, D Karandrea, E Stergiou, E
Petrakakou, A Giachnaki, P Athanassiades
Cytopathology Department
“Laiko” Hospital, Athens, Greece |
| 342 |
Low-density SNP
chip for pharmacogenetic applications
S Hauch, M Lustig, M Heisinger, S Waschütza, E
Schnakenberg
AdnaGen AG,
Hannover-Langenhagen, Lower Saxony Germany |
| 343 |
Tumor-associated
genes differentially expressed in breast tumors regarding
the presence or absence of estrogen and progesterone
receptors
MA Nagai, N Rós, EC Miracca, RLA Silva, AF Carvalho, FB
Runza, LFL Reis, MM Brentani
1Departamento
de Radiologia, Disciplina de Oncologia da Universidade de
São Paulo, São Paulo, Brazil, 2Ludwig
Institute for Cancer Research, São Paulo,
Brazil |
| 344 |
Liver
transplantation due to hepatocellular carcinoma:
prognostic relevance of quantitative DNA
ploidy
H Al-Abadi, T Steinmueller, S Jonas, I Rotter, P
Neuhaus
Department of Surgery,
Charite, Campus Virchow Klinikum, Humboldt University of
Berlin |
| 345 |
A comprehensive
investigation of D-Loop mutations in the mitochondrial
DNA as potential diagnostic molecular markers for
colorectal cancer.
SR Fradley, Genetics
University of Wales
Swansea, Swansea, West Glamorgan United
Kingdom |
| 346 |
Osteopontin
Expression may be induced by c-Src in Papillary Thyroid
Carcinoma
Y Kato, H Zhu, R Tanaka, T Obara, K Sato, T Sawada, M
Kobayashi
1Tokyo
JapanDepartment of General Surgery, Tokyo Women's Medical
University, Shinjuku, First, 2Affiliated
Hospital of Anhui Medical University, Anhui,
China |
| 347 |
Rb and p16
expression characterizes two subgroups of
gastrointestinal poorly differentiated endocrine
carcinomas with different genetic
alterations.
S Pizzi, T D'Adda, C Azzoni, D Bassi, L Bottarelli, M
Milione, C Bordi
Department of Pathology
& Laboratory Medicine - Pathologic Anatomy,
University of Parma, Italy |
| 348 |
READ BY TITLE
Immunosensors for determination of carcinoembryonic
antigen by using solid-phase immunoassay
H Ju, Z Dai, J Chen
Department of Chemistry,
Nanjng University, China |
| 349 |
Prognostic
significance and clinical impact of the
Thomsen-Friedenreich antigen in gastrointestinal
cancer
U Karsten, Y Cao, SE Baldus, H Shigeoka, G Butschak, A
Kramer, S Goletz
1Max
Delbrueck Center for Molecular Medicine, Berlin-Buch,
Germany, 2German Cancer Research Center,
Heidelberg, Germany, 3Department of Pathology,
University of Cologne, Cologne, Germany,
4Kinki University School of Medicine, Osaka,
Japan, 5Nemod GmbH, Berlin-Buch,
Germany |
| 350 |
*Reliability
assessment of soluble c-erbB-2 concentrations in the
saliva of healthy women and men.
C Streckfus, L Bigler, L Copeland
Office of Research,
University of Mississippi Medical Center, Jackson,
MS |
| 351 |
Analysis of
genetic abnormalities in locally advanced breast
carcinomas determined by microsatellite alterations and
p53 gene mutations
SF Picard, N Franco, L Hahnel, M Arnal, S Lizard
Laboratory of Molecular
Genetic, Centre Georges Francois Leclerc, Dijon,
France |
| 352 |
*Proteomic
analysis of beta-catenin during the neoplastic
progression from precursor lesions to invasive squamous
cell carcinoma of the esophagus
MJ Roth, N Hu, CP Paweletz, M Iwamoto, Y-L Qiao, W-J Li,
H Su, DJ Ahnen, SM Dawsey, MD Taylor
1National
Cancer Institute, Bethesda, MD, 2Cancer
Institute, Chinese Academy of Medical Sciences, Beijing,
People’s Republic of China, 3Shanxi Cancer
Hospital and Institute, Taiyuan, Shanxi, People’s
Republic of China, 4University of Colorado
Health Sciences Center, Denver, CO |
| 353 |
Microsatellite
instability in unselected Sardinian patients with
endometrial cancer: screening for hMLH1/hMSH2 and PTEN
germline mutations
P Baldinu, A Cossu, A Manca, MP Satta, M Pisano, M
Casula, S Dessole, A Pintus, F Tanda, G Palmieri
1Institute of
Molecular Genetics, C.N.R, Loc. Tramariglio, 07040 Santa
Maria La Palma, 2, and, Italy,
3Institute of Pathology, and, Italy,
4Department of Obstetric & Gynecology,
University of Sassari, Sassari, Italy |
| 354 |
Transforming
growth factor alpha: a valid surrogate endpoint
biomarker?
SW Beenken, H Jr, WF Malone, KI Bland
1Department
of Surgery, The University of Alabama at Birmingham,
Birmingham, AL, 2Eli Lilly and Co,
Indianapolis, IN, 3Division of Cancer
Prevention, The National Cancer Institute, Bethesda,
MD |
| 355 |
Accurate
detection and identification of Human Papillomavirus
genotypes in archival cervical specimens by
broad-spectrum PCR and reverse hybridization and the
long-term risk identifies risk for development of
cervical carcinoma.
WGV Quint, Y van der Graaf, A Molijn, H Doornewaard, B
Kleter, L van Doorn, JG van den Tweel
1Delft
Diagnostic Laboratory, Delft, and, 2University
Medical Center Utrecht, the Netherlands |
| 356 |
Genetic
polymorphisms in the the human leukocyte antigens (HLA
DRB) loci and non-Hodgkin's lymphoma
outcome.
E Kalinka, P Juszczynski, G Salles, G Woszczek, M
Borowiec, E Lech-Maranda, L Baseggio, M Kowalski, T
Robak, B Coiffier, K Warzocha
1Department
of Hematology, 2Department of Clinical
Immunology; Medical University of Lodz, Poland, and,
3Service d'Hematologie, Centre Hospitalier
Lyon-Sud, Pierre Benite, France |
| 357 |
Urinary tissue
factor: A potential marker of malignant
disease
Dr Bashir, A Lwaleed
Dr Bashir A. Lwaleed,
Department of Urology/Surgery, Level F, Central Block,
Research Group, Mail point, Southampton University
Hospitals NHT Trust |
| 358 |
TP53, MEK1, XIAP,
BCL-2 and BAX as prognostic and predictive factors in
ovarian carcinomas treated with platinum-based
regimen.
J Kupryjanczyk, T Szymanska, R Madry, G Karpinska, A
Rembiszewska, A Timorek, I Ziolkowska, J Stelmachow, J
Zielinski, J Markowska
1Department
of Molecular Biology and Gynecologic Oncology, Oncology
Center, Warsaw, Poznan, 2Department of
Pathology and Obstetrics and Gynecology, Medical Academy
and Brodnowski Hospital, Warsaw, Poznan,
3Department of Gynecologic Oncology, Medical
Academy, Poznan, Poland |
|
Site Contents
- The Journal
- CDP, a peer-refereed
bi-monthly on predictive and preventive oncology
- The Society
- The International Society for Preventive
Oncology
- Meetings
- Network and earn CME credits at our
international symposia.
|
